LEADER 02374ngm  2200541 a 450 
001 9910728789903321
005 20231116231047.0
035   $a(CKB)3780000000053119
035   $a(UkLoHST)2657
035   $a(UkLoHST)HST3533
035   $a(EXLCZ)993780000000053119
071 50$a3533$bHenry Stewart Talks
100   $a20140117d2013      ||         v
101 0 $aeng
135   $aurcna|||a||||
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aProteomics in cardiovascular disease $eclinical considerations /$fChristian Delles
210   $aLondon $cHenry Stewart Talks$d2013
215   $a1 online resource (1 streaming video file (34 min.) $ccolor, sound)
225 1 $aClinical proteomics,$x2056-452X
300   $aAnimated audio-visual presentation with synchronized narration.
300   $aTitle from title frames.
327   $aContents: Systems biology -- Definition of proteomics -- Proteomics: rationale and practical aspects -- Proteomics in cardiovascular pathophysiology -- Proteomics to detect biomarkers of cardiovascular disease -- Urinary proteomics using capillary electrophoresis / mass spectrometry -- Proteomics of coronary artery disease -- Proteomics of pre-eclampsia -- Proteomics of other cardiovascular diseases: stroke, heart failure, diabetic nephropathy.
410  0$aHenry Stewart talks.$pBiomedical & life sciences collection.$pClinical proteomics.
606   $aBiochemical markers
606   $aCardiovascular system$xDiseases
606   $aProteomics$xMethodology
606   $aBiomarkers
606   $aCardiovascular Diseases$xdiagnosis
606   $aCardiovascular Diseases$xphysiopathology
606   $aProteome$xanalysis
606   $aProteomics$xmethods
615  0$aBiochemical markers.
615  0$aCardiovascular system$xDiseases.
615  0$aProteomics$xMethodology.
615  2$aBiomarkers.
615  2$aCardiovascular Diseases$xdiagnosis.
615  2$aCardiovascular Diseases$xphysiopathology.
615  2$aProteome$xanalysis.
615  2$aProteomics$xmethods.
700   $aDelles$b Christian$p(Institute of Cardiovascular & Medical Sciences, University of Glasgow, UK)$4spk$01365587
801  0$bUkLoHST
801  1$bUkLoHST
906   $aVIDEO
912   $a9910728789903321
996   $aProteomics in cardiovascular disease$93387666
997   $aUNINA